TT3A is an innovative Italy-based MedTech startup pioneering the development of the world’s first medical device specifically designed for the endovascular treatment of ascending aortic aneurysms and dissections.
Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and safety, setting the stage for transformative solutions in aortic care.
Company Details
- Founded
- -
- Address
- Via Antiniana, 2 F, Pozzuoli,campania 80078,italy
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://tt3a.com
- HQ
- Pozzuoli, Campania
Tt3a Questions
Tt3A's website is http://tt3a.com
Tt3A's LinkedIn profile is https://it.linkedin.com/company/tt3a
Tt3A's industry is
Medical Equipment Manufacturing
Tt3A's top competitors are
Mgshell S.r.l.,
Balmed,
Numericor Gmbh,
I-Vasc Srl,
Rilemo,
Cerotek,
Nib Biotec,
Squadra Lifesciences, Inc.,
Cerenetex,
Xvivo.
Tt3A's categories are Medical Equipment Manufacturing
Tt3A's founding year is 2022
